Whenever possible, enrollment in clinical trials is strongly recommended; however, a significant proportion of patients lack access to these opportunities. In such cases, treatment options include ...
Tevimbra is under clinical development by BeiGene and currently in Phase II for Soft Tissue Sarcoma. According to GlobalData, Phase II drugs for Soft Tissue Sarcoma have a 26% phase transition success ...
Hearing loss is a common condition that affects hearing, communication, and social skills. Treatment options for hearing loss may be as simple as removing excess earwax, treating underlying conditions ...
But in general, there are a few types of treatment that work for many different kinds of cancer. Here’s a look at some of the options you might have. Most people with cancer will have some type ...
Prostate cancer treatments lead to higher long-term complication rates, emphasizing the need for informed decision-making regarding treatment options and side effects. Prostatectomy patients ...
Pembrolizumab is under clinical development by Merck and currently in Phase II for Anal Cancer. According to GlobalData, Phase II drugs for Anal Cancer have a 19% phase transition success rate (PTSR) ...
Panelists discuss how, coming into ASH 2024, the largest unmet needs in the treatment and management of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) include improving outcomes ...